nhc-logo
Journal metrics
Acceptance rate 7%
Submission to final decision 140 days
Acceptance to publication 22 days
CiteScore 4.700
Journal Citation Indicator 0.760
Impact Factor 4.1
Journal profile
Advances in Pharmacological and Pharmaceutical Sciences publishes original research articles and review articles in all areas of experimental and clinical pharmacology, pharmaceutics, medicinal chemistry and drug delivery.
Editor spotlight
Advances in Pharmacological and Pharmaceutical Sciences maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Special Issues
Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.
Latest Articles
More articles
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was
Research Article
Sensorineural Hearing Loss in Seropositive Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated
The outcome of spontaneous intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was intracranial hypotension (SIH) years after onset is largely unknown. The objective of our study was